Hiv Diagnostics Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

The global HIV diagnostics market comprises laboratory-based testing, rapid diagnostic tests, point-of-care solutions, and home testing kits used to detect HIV infection across healthcare settings worldwide. While market size estimates from various industry analysts range from approximately $1.18 billion to $3.81 billion for 2025, the market is broadly valued at around $2.75 billion and exhibits consistent upward momentum. Official statistical agencies track kit distribution volumes but do not publish direct revenue figures, making independent market research the primary source for market sizing.

• •Estimated at roughly $2.75 billion in 2025 with continued expansion expected through the decade
• •Includes laboratory assays, rapid tests, nucleic acid tests, and self-testing products
• •Market sizing varies across research firms due to differing scope and methodology

Government-led health initiatives and public awareness campaigns are the primary engines of market expansion, with countries and multilateral organizations significantly scaling up testing and treatment programs. The World Health Organization's test-and-treat strategies, which emphasize early diagnosis and immediate treatment initiation, have created sustained demand for diagnostic products. Technological advances in point-of-care and home-based testing are broadening access, particularly in regions with limited laboratory infrastructure.

• •Government health initiatives and public awareness campaigns are heavily driving market growth
• •WHO test-and-treat strategies are influencing testing volumes and product requirements
• •Advances in point-of-care and home testing are expanding access in underserved regions

The market is segmented by product type, end user, and geography, with laboratory-based immunoassays and rapid diagnostic tests representing the largest share of current demand. North America and Europe have historically led in market value due to advanced healthcare infrastructure and higher testing rates, while Asia-Pacific and sub-Saharan Africa are growing fastest as screening programs expand. Home testing and self-testing products represent the fastest-growing product category as regulatory approvals increase and consumer awareness rises.

• •North America and Europe dominate in market value; Asia-Pacific and Africa are the fastest-growing regions
• •Point-of-care and home testing kits are the fastest-expanding product segments
• •Laboratory-based immunoassays and rapid tests remain the largest revenue contributors

What are the recent trends and outlook?

The market is trending toward decentralized testing models, with increasing adoption of rapid diagnostic tests and self-testing kits reducing reliance on centralized laboratory infrastructure. Multiplex testing platforms that detect HIV alongside other infectious diseases are gaining traction, aligning with integrated screening approaches. With projected growth rates between 7% and 10% CAGR across industry estimates, the market is expected to approach $5 billion by 2030, supported by ongoing global commitments to HIV elimination targets.

• •Decentralized and self-testing models are reshaping how HIV testing is delivered globally
• •Multiplex assays combining HIV with hepatitis and other STI testing are gaining adoption
• •The market is projected to reach approximately $5 billion by 2030 under most industry forecasts